SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Shani Eli

(Last)

(First)

(Middle)

C/O TEVA PHARMACEUTICAL INDUSTRIES LTD.

124 DVORA HANEVI'A ST.,

(Street)

TEL AVIV

6944020

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/15/2021

3. Issuer Name and Ticker or Trading Symbol
TEVA PHARMACEUTICAL INDUSTRIES LTD [ TEVA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP,Global Marketing&Portfolio

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares⁽¹⁾	9,091	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Restricted Share Units	⁽²⁾	⁽²⁾	Ordinary Shares⁽¹⁾	6,346	⁽³⁾	D
Restricted Share Units	⁽⁴⁾	⁽⁴⁾	Ordinary Shares⁽¹⁾	1,581	⁽³⁾	D
Restricted Share Units	⁽⁵⁾	⁽⁵⁾	Ordinary Shares⁽¹⁾	23,586	⁽³⁾	D
Restricted Share Units	⁽⁶⁾	⁽⁶⁾	Ordinary Shares⁽¹⁾	15,934	⁽³⁾	D
Stock Options (right to buy)	⁽⁷⁾	08/10/2028	Ordinary Shares⁽¹⁾	16,503	$22.48	D
Stock Options (right to buy)	⁽⁸⁾	03/03/2027	Ordinary Shares⁽¹⁾	13,002	$34.7	D
Stock Options (right to buy)	⁽⁹⁾	03/17/2026	Ordinary Shares⁽¹⁾	13,005	$53.5	D
Stock Options (right to buy)	⁽¹⁰⁾	03/12/2025	Ordinary Shares⁽¹⁾	14,252	$60.21	D
Stock Options (right to buy)	⁽¹¹⁾	03/12/2024	Ordinary Shares⁽¹⁾	15,002	$48.76	D
Stock Options (right to buy)	⁽¹²⁾	02/24/2023	Ordinary Shares⁽¹⁾	4,170	$38.08	D
Stock Options (right to buy)	⁽¹³⁾	02/24/2022	Ordinary Shares⁽¹⁾	2,669	$44.59	D

Explanation of Responses:

1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

2. Restricted share units were granted on March 4, 2019, with 3,173 vesting on each of March 4 2022 and March 4, 2023.

3. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.

4. Restricted share units were granted on August 10, 2018, with 1,581 vesting on August 10, 2022.

5. Restricted share units were granted on March 5, 2021, with 5,896 vesting on each of March 5, 2022, March 5, 2023 and March 5, 2024 and 5,898 vesting on March 5, 2025.

6. Restricted share units were granted on February 28, 2020, with 5,311 vesting on each of February 28, 2022 and February 28, 2023 and 5,312 vesting on February 28, 2024.

7. Stock options were granted on August 10, 2018, with 4,152 vesting on each of August 10, 2019, August 10, 2020 and August 10, 2021 and 4,128 vesting on August 10, 2022.

8. Stock options were granted on March 3, 2017, with 3,250 vested on each of March 3, 2018, March 3, 2019 and March 3, 2020 and 3,252 vested on March 3, 2021.

9. Stock options were granted on March 17, 2016, with 3,251 vested on each of March 17, 2017, March 17, 2018 and March 17, 2019 and 3,252 vested on March 17, 2020.

10. Stock options were granted on March 12, 2015, with 3,563 vested on each of March 12, 2016, March 12, 2017, March 12, 2018 and March 12, 2019.

11. Stock options were granted on March 12, 2014, with 5,000 vested on each of March 12, 2015 and March 12, 2016 and 5,002 vested on March 12, 2017.

12. Stock options were granted on February 24, 2013, with 4,170 having vested on February 24, 2016.

13. Stock options were granted on February 24, 2012, with 2,669 vested on February 24, 2016.

Remarks:

	/s/ Dov Bergwerk as attorney-in-fact for Eli Shani	08/19/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.